Format: | Cassette | Specimen: | Whole Blood,serum,plasma |
---|---|---|---|
Kit Size: | 25T/Kit | Cut-Off: | See Insert |
Storage: | 2-30℃ | Shelf Time: | 24 Months |
High Light: | rapid test kit,infectious disease diagnostic tests |
AllTest High Sensitivity Mycoplasma pneumoniae Antigen Lateral Flow Immunochromatographic Assays Rapid Test with CE
Applications:
Mycoplasma pneumoniae Antigen Rapid Test Cassette is a rapid chromatographic immunoassay for the qualitative detection of Mycoplasma pneumoniae(M. pneumoniae) antigens in human throat swabs. It is intended to aid in the rapid differential diagnosis of Mycoplasma pneumoniae infections.
Description:
M. pneumoniae is one of three species of Mycoplasma that frequently cause infection in humans. M. pneumoniae most commonly causes upper respiratory tract infections, but can also cause pneumonia. The identification of the M. pneumoniae will help the administration of the disease with appropriate antibiotic treatment. This M. pneumoniae immunoassay is intended to detect M. pneumoniae antigen qualitatively. Because this one-step M. pneumoniae rapid test is easy to carry out, it is widely used as a screening test device and as an aid in the diagnostics of M. pneumoniae disease.
How to use?
INTERPRETATION OF RESULTS
(Please refer to the illustration above)
POSITIVE: Two colored lines appear. One colored line appears in the control region(C), and one colored line in the test region(T). The shade of color may vary,but it should be considered positive whenever there is even a faint line.
NEGATIVE: Only one colored line appears in the control region(C), and no line in the test region(T). The negative result indicates that there are no M. pneumoniae in the sample or the number of M. pneumoniae is below the detectable range.
INVALID: No line appears in the control region(C). The test is invalid even if there is a line on test region(T). Insufficient sample volume or incorrect procedural techniques are the most likely reasons for control line failure. Review the test procedure and repeat the test using a new test device. If the problem persists, discontinue using the test kit immediately and contact your local distributor.
Cat. No. | Product Description | Specimen | Format | Kit Size | Cut-Off | Status |
IMP-502 |
Mycoplasma Pneumoniae Antigen Rapid Test |
Swab | Cassette | 20T | See Insert | CE |
5 Facts You Need to Know about Mycoplasma pneumoniae
In recent times, there has been a notable increase in cases of pediatric pneumonia linked to Mycoplasma pneumoniae (MP) in several countries, including China, Denmark, France, the Netherlands, and specific regions in the United States. This rise has raised concerns on a global scale. Although MP is known to cause occasional outbreaks, experts believe that the current increase may be more significant than usual, particularly in Europe and Asia, where reported cases have quadrupled compared to previous years.
In order to understand what MP is all about, here are 5 facts listed below.
1. MP infections typically present with mild symptoms such as low-grade fever, dry cough, mild shortness of breath (especially during physical activity), and fatigue.
The symptoms of Mycoplasma pneumonia (MP) differ from those caused by typical pneumonia bacteria like Streptococcus and Haemophilus. MP infections generally do not exhibit severe shortness of breath, high fever, or productive cough. Instead, patients commonly experience low-grade fever, dry cough, mild shortness of breath (especially during physical activity), and fatigue. MP can sometimes resemble an upper respiratory infection or common cold rather than a lower respiratory infection or pneumonia. The most prominent sign of infection is a dry cough. Other possible symptoms may include malaise and mild shortness of breath.
In rare cases, MP infections can lead to serious complications affecting various organs and systems, such as joint inflammation (arthritis), inflammation of the pericardium surrounding the heart (pericarditis), Guillain-Barré syndrome (a neurological disorder), encephalitis (inflammation of the brain), kidney failure, hemolytic anemia, rare skin conditions like Stevens-Johnson syndrome and toxic epidermal necrolysis, and rare ear problems like bullous myringitis. Although rare, MP infections can occasionally be fatal.
Mycoplasma is found in the throat of infected persons and is spread to other people through the air by sneezing or coughing. It can also be spread by touching tissues or other things recently soiled by secretions from the nose or throat of an infected person.
In particular, there has been a significant surge in Mycoplasma pneumoniae infections among children in multiple areas recently.
Most people will recover from an infection caused by Mycoplasma pneumoniae without antibiotics. Ask your doctor or pharmacist about over-the-counter medicines that can help you feel better while you are recovering.
However, if someone develops pneumonia (lung infection) caused by M. pneumoniae, doctors usually prescribe antibiotics. There are several types of antibiotics available to treat pneumonia caused by M. pneumoniae. Early detection and appropriate treatment with antibiotics can help manage the infection and prevent complications. However, it's important to note that some strains of Mycoplasma pneumoniae have developed resistance to certain antibiotics, highlighting the significance of responsible antibiotic use.
The risk of contracting MP peaks in the fall and winter months. Close or crowded places make it easy for the infection to transmit from person to person.
To lower your risk of Mycoplasma pneumonia (MP) infection, it is recommended to follow these preventive measures:
For others, symptoms should subside 1 to 2 weeks after treatment. A cough may linger, but most cases resolve with no lasting consequences within 4 to 6 weeks.
See your doctor if you continue to experience severe symptoms or if the infection is interfering with your daily life. You may need to seek treatment or a diagnosis for any other conditions that your MP infection might’ve caused.